A

Adaptimmune (ADAP)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Adaptimmune (ADAP)

Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company is focused on cancer immunotherapy products based on its Specific Peptide Enhanced Affinity Receptor (SPEAR) T-cell platform. Its SPEAR T-cell platform enables it... Read more

  • 1.73
  • 1.83
  • 1.63
  • 4.17
  • 8.4%
  • 14M
  • 243.40k
  • 510.67k
  • 337M
  • 1.01
  • -53.7%
  • %

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.